Codice QR

COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis

ObjectiveTo evaluate the safety of COVID-19 vaccines in patients with multiple sclerosis (MS) by assessing their impact on serum neurofilament light chain (sNfL) levels as a marker of neuroaxonal damage.MethodsSingle-center observational longitudinal study including patients with MS who consecutivel...

Descrizione completa

Salvato in:
Autori principali: Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Raquel Sainz-Amo, Lucienne Costa-Frossard, Jaime Masjuan, Luisa María Villar
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2024-08-01
Serie:Frontiers in Immunology
Soggetti:
SARS-CoV-2 immunization
neuroaxonal damage
sNfL
multiple sclerosis
COVID-19 vaccines
safety
Accesso online:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1439393/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi